Has Christopher Fabian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,280 in general payments to Christopher Fabian, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Fabian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Fabian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Fabian, MD

Psychiatry · New York, NYNPI 1649328923

Payments from drug & device makers

$1,280in general payments, 2019–2025

Across 82 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$277
Johnson & Johnson$214
Sunovion Pharmaceuticals Inc.$151
Novo Nordisk$122
Alkermes, Inc.$113
Otsuka America Pharmaceutical, Inc.$112
plus $292 from 8 others

What the payments were for

Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	24	$277
Johnson & Johnson	15	$214
Sunovion Pharmaceuticals Inc.	10	$151
Novo Nordisk	1	$122
Alkermes, Inc.	7	$113
Otsuka America Pharmaceutical, Inc.	7	$112
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$80
Neurocrine Biosciences, Inc.	3	$54
Teva Pharmaceuticals USA, Inc.	2	$38
E.r. Squibb & Sons, L.L.C.	2	$34
Braeburn Inc.	2	$32
Indivior Inc.	2	$31
Axsome Therapeutics, Inc.	1	$13
Life Molecular Imaging Ltd	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Ozempic$122

How this compares

$1,280 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Medicare billing

Part B allowed, 2024

$50,329

Medicare patients

115

Services billed

488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lurasidone Hcl	18	$1,397
Pantoprazole Sodium	30	$453
Atorvastatin Calcium	32	$449
Divalproex Sodium	16	$404
Olanzapine	19	$369
Gabapentin	18	$304
Quetiapine Fumarate	21	$293
Amlodipine Besylate	35	$290
Risperidone	18	$167
Trazodone Hcl	27	$151
Escitalopram Oxalate	20	$137
Doxepin Hcl	15	$123
Lithium Carbonate	11	$84
Levothyroxine Sodium	12	$79
Clonazepam	12	$52

Paid to pharmacies, not to this prescriber.

Other psychiatry in New York

Michael LiebowitzNew York$7.1M
Paul EderNew York$2.7M
Lenard AdlerNew York$1.8M
Ram ShrivastavaNew York$1.8M
Jonathan KaneNew York$1.8M
Eric HollanderNew York$1.4M
William HapworthNew York$1.3M
Manish ZinzuvadiaNew York$1.3M
Jianping ChenNew York$1.2M
Anthony ZoghbiNew York$1.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →